trending topics
market reports
-
Visit MEDICAL JAPAN 2023 TOKYO and take full advantage of the business opportunities!
2023-09-01
-
US to distribute 400 million free N95 masks at CVS, Walgreens in COVID fight
2022-01-21
-
Ethiopia receives additional 2.2 mln doses of Chinese-donated COVID-19 vaccines
2022-01-21
-
Hong Kong researchers say they develop novel material able to kill COVID-19 virus
2022-01-14
-
10 million more Chinese doses on way for Kenya
2022-01-14
-
Sino-African ties on track for a brighter future
2022-01-07
-
Efforts urged to boost COVID-19 vaccine production capacity in poor countries
2022-01-07
-
UAE approves Sinopharm's new protein-based COVID-19 vaccine
2022-01-07
-
UAE approves Sinopharm's new protein-based COVID-19 vaccine
2022-01-07
-
Zimbabwe buoyed by Chinese jabs
2021-12-31
-
China's foreign trade grows at faster pace despite challenges
2023-05-24 -
First domestic ECMO machine to play vital role
2023-01-09 -
US to distribute 400 million free N95 masks at CVS, Walgreens in COVID fight
The US government will make 400 million non-surgical "N95" masks from its strategic national stockpile available for free to the public starting next week.
2022-01-21 -
Hong Kong researchers say they develop novel material able to kill COVID-19 virus
The Hong Kong Polytechnic University (PolyU) announced on Thursday that its research team has successfully developed "anti-virus 3D printing material" that can kill the COVID-19 virus on surfaces as well as most common viruses and bacteria.
2022-01-14 -
Efforts urged to boost COVID-19 vaccine production capacity in poor countries
Not allowing poorer countries to produce coronavirus vaccines to protect their people has been "one of the global failures" in the battle against the COVID-19 pandemic, a leading British health academic told Xinhua.
2022-01-07 -
Bangladesh to administer 40 mln doses of COVID-19 vaccines every month from January
Bangladesh will administer 40 million doses of COVID-19 doses every month from January next year, a minister has said.
2021-12-31 -
Nation's antibody therapy could be in use soon
China's domestically developed monoclonal neutralizing antibody therapy for COVID-19 treatment could be used clinically in the country within weeks after it was included in the country's Diagnosis and Treatment Protocol for COVID-19
2021-12-24 -
Efforts to study TCM's clinical efficacy on virus
China will ramp up efforts to accumulate evidence on traditional Chinese medicine's efficacy against COVID-19 and clarify how it works, TCM officials and experts said on Thursday.
2021-12-17 -
Antibody combination therapy approved to treat COVID-19
China approved on Wednesday the use of a monoclonal neutralizing antibody cocktail for COVID-19 treatment created by Brii Biosciences.
2021-12-10 -
Expertise from China tapped for treatments
Chinese drugmakers are working with global counterparts in the race to find game-changing treatments for COVID-19 and help nations recover faster from the pandemic.
2021-12-03